307 related articles for article (PubMed ID: 15598946)
1. Impact of EGFR expression on colorectal cancer patient prognosis and survival.
Spano JP; Lagorce C; Atlan D; Milano G; Domont J; Benamouzig R; Attar A; Benichou J; Martin A; Morere JF; Raphael M; Penault-Llorca F; Breau JL; Fagard R; Khayat D; Wind P
Ann Oncol; 2005 Jan; 16(1):102-8. PubMed ID: 15598946
[TBL] [Abstract][Full Text] [Related]
2. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
3. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
[TBL] [Abstract][Full Text] [Related]
4. Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers.
Yue Y; Astvatsaturyan K; Cui X; Zhang X; Fraass B; Bose S
PLoS One; 2016; 11(3):e0149661. PubMed ID: 26930401
[TBL] [Abstract][Full Text] [Related]
5. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma.
Du P; Xu B; Zhang D; Shao Y; Zheng X; Li X; Xiong Y; Wu C; Jiang J
Oncotarget; 2017 Jan; 8(1):954-966. PubMed ID: 27888614
[TBL] [Abstract][Full Text] [Related]
6. Concomitant tumor expression of EGFR and TATI/SPINK1 associates with better prognosis in colorectal cancer.
Koskensalo S; Louhimo J; Hagström J; Lundin M; Stenman UH; Haglund C
PLoS One; 2013; 8(10):e76906. PubMed ID: 24204699
[TBL] [Abstract][Full Text] [Related]
7. Expression of epidermal growth factor receptor (EGFR) in colorectal cancer: An immunohistochemical study.
Ben Brahim E; Ayari I; Jouini R; Atafi S; Koubaa W; Elloumi H; Chadli A
Arab J Gastroenterol; 2018 Sep; 19(3):121-124. PubMed ID: 30243897
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: a tissue microarray study.
Resnick MB; Routhier J; Konkin T; Sabo E; Pricolo VE
Clin Cancer Res; 2004 May; 10(9):3069-75. PubMed ID: 15131045
[TBL] [Abstract][Full Text] [Related]
9. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
10. Human epidermal growth factor receptor-2 family in colorectal adenocarcinoma: correlation with survival and clinicopathological findings.
Molaei M; Pejhan S; Nayer BN; Moradi A; Ghiasi S; Zali MR
Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):289-93. PubMed ID: 19279475
[TBL] [Abstract][Full Text] [Related]
11. Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer.
Larsson AH; Lehn S; Wangefjord S; Karnevi E; Kuteeva E; Sundström M; Nodin B; Uhlén M; Eberhard J; Birgisson H; Jirström K
J Transl Med; 2016 May; 14(1):128. PubMed ID: 27160084
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of p53, c-erbB-2 and epidermal growth factor receptor on head and neck carcinoma.
Parise Junior O; Carvalho LV; Miguel RE; Kowalski LP
Sao Paulo Med J; 2004 Nov; 122(6):264-8. PubMed ID: 15692721
[TBL] [Abstract][Full Text] [Related]
13. Concurrent EGFr and Cox-2 expression in colorectal cancer: proliferation impact and tumour spreading.
Ceccarelli C; Piazzi G; Paterini P; Pantaleo MA; Taffurelli M; Santini D; Martinelli GN; Biasco G
Ann Oncol; 2005 May; 16 Suppl 4():iv74-79. PubMed ID: 15923435
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor expression correlates with poor survival in gastric adenocarcinoma from Mexican patients: a multivariate analysis using a standardized immunohistochemical detection system.
Gamboa-Dominguez A; Dominguez-Fonseca C; Quintanilla-Martinez L; Reyes-Gutierrez E; Green D; Angeles-Angeles A; Busch R; Hermannstädter C; Nährig J; Becker KF; Becker I; Höfler H; Fend F; Luber B
Mod Pathol; 2004 May; 17(5):579-87. PubMed ID: 15073595
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer.
Tsutsui S; Ohno S; Murakami S; Hachitanda Y; Oda S
Breast Cancer Res Treat; 2002 Jan; 71(1):67-75. PubMed ID: 11859875
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation, but not overexpression, of epidermal growth factor receptor is associated with poor prognosis of non-small cell lung cancer patients.
Kanematsu T; Yano S; Uehara H; Bando Y; Sone S
Oncol Res; 2003; 13(5):289-98. PubMed ID: 12688680
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system.
Rokita M; Stec R; Bodnar L; Charkiewicz R; Korniluk J; Smoter M; Cichowicz M; Chyczewski L; Nikliński J; Kozłowski W; Szczylik C
Onco Targets Ther; 2013; 6():967-76. PubMed ID: 23926437
[TBL] [Abstract][Full Text] [Related]
18. The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients.
Fox SB; Smith K; Hollyer J; Greenall M; Hastrich D; Harris AL
Breast Cancer Res Treat; 1994 Jan; 29(1):41-9. PubMed ID: 8018963
[TBL] [Abstract][Full Text] [Related]
19. Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer.
Mitsui K; Yonezawa M; Tatsuguchi A; Shinji S; Gudis K; Tanaka S; Fujimori S; Sakamoto C
BMC Cancer; 2014 Nov; 14():863. PubMed ID: 25416285
[TBL] [Abstract][Full Text] [Related]
20. Serine Protease Inhibitor Kazal Type 1 (SPINK1) Promotes Proliferation of Colorectal Cancer Through the Epidermal Growth Factor as a Prognostic Marker.
Chen YT; Tsao SC; Yuan SS; Tsai HP; Chai CY
Pathol Oncol Res; 2015 Sep; 21(4):1201-8. PubMed ID: 26037168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]